Cytotoxic and Anti-HIV Phenanthroindolizidine Alkaloids from Cryptocarya chinensis by Wu, Tian-Shung et al.
Cytotoxic and Anti-HIV Phenanthroindolizidine Alkaloids from
Cryptocarya chinensis
Tian-Shung Wua,b,c,*, Chung-Ren Sua, and Kuo-Hsiung Leec,d,*
aDepartment of Chemistry, National Cheng Kung University, Tainan 701, Taiwan
bDepartment of Pharmacy, China Medical University, Taichung 404, Taiwan
cChinese Medicinal Research and Development Center, China Medical University and Hospital,
Taichung 401, Taiwan
dNatural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of
North Carolina, Chapel Hill, North Carolina 27599-7568, USA
Abstract
Bioassay-guided fractionation of the cytotoxic ethanol extract of Cryptocarya chinensis has led to
the isolation of 11 compounds, including two phenanthroindolizidine alkaloids [(−)-antofine (1)
and dehydroantofine (2)], five pavine alkaloids (3–7), and four proaporphine alkaloids (8–11). The
structures of the isolated compounds were determined by means of NMR spectroscopic methods,
and supported by HRMS and optical rotation data. Compounds 1 and 2 showed cytotoxic activity
against four cancer cell lines, L1210, P388, A549, and HCT-8, with 1 being the most potent
against A549 and HCT-8 with EC50 values of 0.002 and 0.001 μg/mL, respectively. In addition, 2
is first reported to exhibit significant anti-HIV activity.
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Since the first isolation of tylophorine in 1935 from the perennial climbing plant Tylophora
indica [1], the number of phenanthroindolizidine alkaloids reported has grown considerably,
presently encompassing close to 100 structurally related phenanthroindolizidines and
phenanthroquinolizidines, together with their seco-derivatives and N-oxides [2]. These
alkaloids exhibit various biological effects, including antitumor, antiamoebic, antibacterial,
antiviral, anti-inflammatory, antimicrobial, antioxidant, and antifungal activities [2]. In folk
medicine, phenanthroindolizidine alkaloids have been used as emetic, expectorant, and
antipyretic agents [3], These alkaloids have been isolated principally from the
Asclepiadaceae family, most importantly from the genera Tylophora, Vincetoxicum,
Pergularia, and Cynanchum, but also from Hypoestes spp. (Acanthaceae), Cryptocarya spp.
(Lauraceae), and Ficus spp. (Moraceae) [4].
The genus Cryptocarya, which includes about 350 species, is a rich source of secondary
metabolites, such as flavonoids, pyrones, lignans, terpenoids, pavine, and proaporphine
alkaloids [5]. C. chinensis (Hance) Hemsl. (Lauraceae) is an evergreen tree widely
distributed in low-altitude forests in Taiwan and southern China [6]. Few
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we report the isolation of (−)-antofine (1) as a potent cytotoxic principle and
dehydroantofine (2) as an anti-HIV agent. In addition, other types of alkaloids (3–11) were
also isolated from this plant.
From the basic extract of C. chinensis wood, bioassay-guided fractionation and isolation led
to the identification of the two active alkaloids (1 and 2). Comparison of 1H and 13C NMR
spectra and optical rotation data with those from the literature suggested 1 to be (−)-antofine
[8]. This alkaloid was previously isolated from C. phellostemmon and assigned the absolute
configuration 13aR from its CD spectrum [7]. Thus, while phenanthroindolizidine alkaloids
with the S configuration at C-13a exhibit a positive optical rotation measured at the sodium
D line and a positive Cotton effect around 260 nm, the opposite is observed for alkaloids
with the 13aR configuration [9]. The CD spectrum of 1 was in agreement with this rule.
Thus, alkaloid 1 was unambiguously identified as (−)-(R)-13aα-antofine[8, 10].
Compound 2, obtained as a yellow crystalline solid, has the molecular formula C23H27NO5,
as determined from HR-FAB MS data. The strong absorption bands in the UV spectrum at
322 nm and 283 nm were similar to those of dehydro derivatives of phenanthroindolizidine
alkaloids [11], Examination of coupling patterns in the 1H NMR spectrum and
connectivities in the COSY and NOESY spectra of 1 and 2 allowed identification of the
latter as a 9, 14-didehydro derivative of 1. This assignment was supported by the appearance
of two strongly deshielded proton singlets at δ 9.68 and 8.51 assignable to H-9 and H-14 of
ring D, which showed NOESY correlations with H-8 and H-1, respectively. From all the
data, the structure of 2 was postulated as dehydroantofine. To the best of our knowledge,
this compound was previously isolated from C. phyllostemon and identified on the basis of
its 1H NMR spectrum alone [7]. Hence, we provide here the detailed spectroscopic data for
the first time (Table 1).
Cytotoxic activity of the isolated alkaloids (1–11) was assessed in vitro against human
leukemia (L-1210), murine lymphocytic leukemia (P-388), human pulmonary cancer
(A-549), and human colon cancer (HCT-8) cell lines. Compound 1 exhibited significant cell
growth suppression against all four cell lines with EC50 values less than 0.1 μg/mL, whereas
its dehydro analogue, 2, showed only moderate activity. In prior structure-activity
relationship (SAR) studies of various natural cytotoxic phenanthroindolizidine alkaloids, it
was found that (i) a rigid phenanthrene structure is a prerequisite for significant cytotoxic
activity, (ii) the unshared electron pair on nitrogen is important for high potency, and (iii)
the cytotoxic potency is highly sensitive to the substitution types and patterns on the
phenanthrene ring [12]. As expected, based on the prior SAR, the degree of unsaturation in
the indolizidine played a crucial role in the cytotoxic effects of phenanthroindolizidines 1
and 2. While the planarity and rigidity of the indolizidine in dehydro 2 would be increased
by the presence of double bonds adjacent to the phenanthrene nucleus, the cytotoxic activity
of 2 was substantially reduced relative to 1.
Interestingly, in an in vitro anti-HIV assay, 2, but not 1, suppressed HIV-infected H9 cell
growth significantly, with an EC50 value of 1.88 μg/mL (Table 2). This promising finding is
the first example of a dehydrophenanthroindolizidine alkaloid exhibiting anti-HIV activity.
Thus, this compound type might provide a useful lead for anti-AIDS drug development.
In addition, other types of alkaloids were also purified from the active fraction. These
compounds were pavine alkaloids 3–7 [(−)-6-hydroxycrychine (3), (−)-12-
hydroxyeschscholtizidine (4), (+)-eschscholtzidine (5), (+)-eschscholtzidine-N-oxide (6),
and (−)-argemonine (7)], as well as proaporphine alkaloids 8–11 [cryprochine (8),
isocryprochine (9), (+)-8,9-dihydrostepharine (10), and prooxocryptochine (11) [13].
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In conclusion, the isolation of 1 and 2 from C. chinensis has been reported for the first time.
Based on the cytotoxicity data of 1 and 2, the degree of unsaturation of the indolizidine
moiety played a crucial role in the cytotoxic potency, with 1 being significantly more potent
than its dehydro analogue 2. Most notably, this report is the first to show significant anti-
HIV activity with a dehydrophenanthroindolizidine (2).
Experimental
General
Melting points, Yanagimoto MP-S3 micro melting point apparatus; Optical rotations,
JASCO DIP-370 digital polarimeter; UV, Hitachi U-3210 spectrophotometer; IR, Shimadzu
FT-IR Prestige-21 spectrophotometer; 1D and 2D NMR, Bruker AVANCE-300
spectrometers; FABMS, JEOL JMS-700 spectrometer; EIMS, VG-70-250S spectrometer;
CC, silica gel (70–230 mesh, 230–400 mesh). TLC was conducted on precoated Kieselgel
60 F 254 plates (Merck) and the compounds were detected either by examining the plates
under a UV lamp or by treating the plates with a 10% methanolic solution of p-anisaldehyde
followed by heating at 110°C.
Plant materials
The wood of C. chinensis was collected from Kaohsiung Hsien in Taiwan in July 2004 and
identified by Prof. C. S. Kuoh, Department of Life Science, National Cheng Rung
University. A voucher specimen (Kuoh 040007) was deposited in the Herbarium of National
Cheng Kung University, Tainan, Taiwan.
Extraction and isolation
The plant material (10.0 kg) was powdered and extracted with 95% EtOH (10 × 25 L) at
room temperature and filtered. The combined filtrate was concentrated and dissolved in 3%
HOAc. The acidic solution was neutralized with NH4OH (aq) and the alkaloids were
extracted with CHCl3. This alkaloidal layer was extracted with 2% NaOH, and then the
organic layer was acidified with 2% H2SO4. The resulting acidic solution was neutralized
with 10% NaOH and partitioned with diethyl ether. (−)-Antofine (1, 18 mg) was obtained
directly from the diethyl ether condensate and recrystallized from acetone. After filtration of
1, the remaining bioactive condensate (11 g) was chromatographed on silica gel and eluted
with a gradient of benzene and acetone (19:1–1:1) to afford 2 (10.8 mg), 3 (16.1 mg), 4





UV (MeOH) λmax (log ε): 372 (3.70), 322 (3.80), 302 (3.20), 283 (3.10), 258 (3.60) nm
IR(KBr) vmax: 3353 3103, 1610, 1521, 1475, 1276 cm−1.
Cytotoxicity assay
Compounds were tested according to procedures described by Rubinstein et al. [14] against
L-1210, P-388, A-549, and HCT-8 cancer cell lines. Samples were prescreened at 40, 4, 0.4,
and 0.04 or at 50, 5, 0.5, and 0.05 μg/mL, against selected HTCL with duplicate dose
treatments and three-day exposure. Results between replicates varied by no more than 5%.
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This assay was performed using methods as described previously in the literature [15].
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Chemical structures of (−)-antofine (1) and dehydroantofine (2).
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Table 1
1H and 13C NMR spectroscopic data of dehydroantofine (2) in CD3OD.
position δc δII HMBC NOESY
1 106.7 7.50 (1H, s) H-14, OCH3-2
2 151.0 H-1, H-4, OCH3-2
3 159.3 H-1, H-4, OCH3-3
4 105.1 7.20 (1H, s) H-5, OCH3-3
4a 128.3 H-1, H-4
4b 132.0 H-4, H-5, H-8
5 117.1 7.22 (1H, d, J=2.4Hz) H-7 H-4, OCH3-6
6 161.6 H-5, H-7, H-8, OCH3-6
7 106.2 7.10(1H, dd, J=8.8, 2.4 Hz) H-8 OCH3-6, H-8
8 125.8 8.20 (1H, d, J=8.8Hz) H-7 H-7, H-9
8a 119.4 H-5, H-7, H-9
8b 125.3 H-14
9 137.6 9.68 (1H, s) H-11 H-8
11 59.5 4.87 (2H, t, J=7.2 Hz) H-12, H-13 H-12
12 22.8 2.60(2H, p, J=7.2 Hz) H-11, H-13 H-11, H-13
13 32.3 3.53 (2H, t, J=7.2 Hz) H-11, H-12, H-14 H-12
13a 151.2 H-9, H-11, H-13
14 117.3 8.51 (1H, s) H-13 H-1
14a 139.3 H-1, H-9
14b 120.4 H-4, H-14
OCH3-2 56.7 3.98 (3H, s) H-1
OCH3-3 56.2 3.99 (3H, s) H-4
OCH3-6 57.0 3.95 (3H, s) H-5, H-7
a
Abbreviations: s single, d doublet, dd double doublet, t triplet multiplet.
b
J in Hz.
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